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Abstract
Background: Aspergillus fumigatus, a saprophytic mould, is responsible for life-threatening, invasive
pulmonary diseases in immunocompromised hosts. The role of the airway epithelium involves a
complex interaction with the inhaled pathogen. Antimicrobial peptides with direct antifungal and
chemotactic activities may boost antifungal immune response.
Results: The inducible expression of defensins by human bronchial epithelial 16HBE cells and A549
pneumocyte cells exposed to A. fumigatus was investigated. Using RT-PCR and real time PCR, we
showed an activation of hBD2 and hBD9 defensin genes: the expression was higher in cells exposed
to swollen conidia (SC), compared to resting conidia (RC) or hyphal fragments (HF). The kinetics
of defensin expression was different for each one, evoking a putative distinct function for each
investigated defensin. The decrease of defensin expression in the presence of heat-inactivated
serum indicated a possible link between defensins and the proteins of the host complement system.
The presence of defensin peptide hBD2 was revealed using immunofluorescence that showed a
punctual cytoplasmic and perinuclear staining. Quantification of the cells stained with anti hBD2
antibody demonstrated that SC induced a greater number of cells that synthesized hBD2,
compared to RC or HF. Labelling of the cells with anti-hBD-2 antibody showed a positive
immunofluorescence signal around RC or SC in contrast to HF. This suggests co-localisation of
hBD2 and digested conidia. The HBD2 level was highest in the supernatants of cells exposed to SC,
as was determined by sandwich ELISA. Experiments using neutralising anti-interleukine-1β antibody
reflect the autocrine mechanism of defensin expression induced by SC. Investigation of defensin
expression at transcriptional and post-transcriptional levels demonstrated the requirement of
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transcription as well as new protein synthesis during A. fumigatus defensin induction. Finally, induced
defensin expression in primary culture of human respiratory cells exposed to A. fumigatus points to
the biological significance of described phenomena.
Conclusion: Our findings provide evidence that respiratory epithelium might play an important
role in the immune response during Aspergillus  infection. Understanding the mechanisms of
regulation of defensin expression may thus lead to new approaches that could enhance expression
of antimicrobial peptides for potential therapeutic use during aspergillosis treatment.
Background
Aspergillus fumigatus (A. fumigatus) is a saprophytic
mould that is responsible for life-threatening invasive
pulmonary diseases in immunocompromised hosts. In
general,  A. fumigatus is propagated through airborne
conidia [1]. Despite the availability of new antifungal
drugs, the number of deaths due to invasive aspergillosis
has progressively increased in the last decades with a rise
in the number of immunosuppressed patients in mod-
ern clinical practices [2]. Therefore, a better understand-
ing of the mechanisms responsible for resistance to
Aspergillus infection is required. The respiratory epithe-
lium plays an important role in the innate immune
defence against various inhaled pathogens by sensing
the signal from the external environment and stimulat-
ing the synthesis of the antimicrobial molecules directly
affecting the microbes [3]. The defensin family of anti-
microbial peptides is an evolutionary conserved group of
small cationic peptides involved in the innate immune
system of plants and animals. They are divided into α-,
β- and θ-defensins, which differ from one another by the
spacing and connectivity of their six cystein residues [4].
It was found that α-defensins are generally stored in the
azurophilic granules of neutrophils and Peneth cells of
the small intestine [5]. Defensins isolated from rhesus
monkey neutrophils are referred to as θ-defensins
because of their circular molecular structure [6]. Human
β-defensins (hBD) are characteristic of epithelial tissue;
they have been identified by traditional peptide purifica-
tion, genomics-based searches [7-9] and an ORFeome-
based peptide database search [10]. Some of these
defensins are tissue-specific, whereas others are
expressed in the epithelium of different origins: hBD1 is
expressed in most epithelial cells [11,12], while hBD2 is
most commonly expressed in the lung and thymus
[13,14]. Newly discovered defensin hBD9 was found to
be ubiquitously expressed in most tissues [10]. Inducible
hBD2 expression by the epithelial cells exposed to
microbial pathogens is well documented [15]. The direct
killing of microorganisms has been ascribed to human
defensins [7]. It was recently recognised that defensins
have additional activities such as the chemoattraction of
immature dendritic cells, T cells and monocytes, as well
as activation of the professional antigen-presenting cells
[16-18]. Killing of A. fumigatus by rabbit neutrophil cati-
onic peptides [19], as well as antifungal activities of
hBD2 against A. fumigatus [20], has been reported in in
vitro experiments. Moreover, the expression of human
drosomycin-like defensins, which display a broad spec-
trum of activity against Aspergillus spp, was found in sev-
eral human tissues [21].
The role of the airway epithelium is not limited to the
first mechanical barrier, but instead involves a complex
interaction with A. fumigatus [22-24]. We hypothesized
that various defensins may be expressed by the respira-
tory epithelium exposed to A. fumigatus. Taking the pos-
sibility into account that some host immunological
reactions are A. fumigatus morphotype-specific [25,26],
the present study has been designed to investigate the
expression of defensins by human pneumocytes and
bronchial epithelial cells exposed to different forms of A.
fumigatus: RC, SC or HF. The expression of previously
studied hBD1 [4] and hBD2 [14,15], as well as recently
discovered hBD8, hBD9 and hBD18 [10], were analysed.
Since hBD2 and hBD9 were found to be highly expressed
by cells exposed to A. fumigatus, those defensins were
chosen for further analysis in the current study. The
inducible expression of hBD2 and hBD9 was revealed by
RT-PCR in airway epithelial cells exposed to A. fumigatus
organisms. Real time PCR demonstrated that the expres-
sion was higher in cells exposed to SC, compared to RC
or HF. The presence of the intracellular hBD2 peptide
was demonstrated using immunofluorescence. The
HBD2 level was highest in the supernatants of cells
exposed to SC, as determined by sandwich ELISA. Fur-
thermore, it was found that transcriptional and post-
transcriptional mechanisms are involved in the regula-
tion of defensin expression. Detection of inducible
defensin expression in human airway primary culture
epithelial cells was proof of the biological significance of
obtained results. Our finding that hBD2 and hBD9 are
expressed and produced (hBD2) in human respiratory
epithelial cells exposed to A. fumigatus is novel and indi-
cates that respiratory epithelium might play an impor-
tant role in the early immune response during Aspergillus
infection.BMC Microbiology 2009, 9:33 http://www.biomedcentral.com/1471-2180/9/33
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Results
Expression of defensins by human pneumocytes and 
bronchial epithelial cells exposed to A. fumigatus
The expression of human defensins, hBD1 and hBD2, and
newly described hBD8, hBD9 and hBD18, by the human
pneumocytes A549 and bronchial epithelial cells 16HBE
exposed to SC, RC or HF of A. fumigatus in the presence of
Fetal Calf Serum was analysed by RT-PCR performed
under the conditions presented in Table 1. The powerful
defensin inductor, Il-1β, was used in experiments as a pos-
itive control. The cells were exposed either to 106 of A.
fumigatus conidia, 20 μl of A. fumigatus HF solution, or 5
× 106 latex beads for 18 h. Compared to the control sam-
ples containing the untreated cells, an inducible expres-
sion of human beta defensins (hBD) 2, 8, 9 and 18 by
16HBE cells exposed to Il-1β was observed (Figure 1).
Exposure of the cells to all of the morphotypes of A. fumi-
gatus resulted in the strong inducible expression of hBD2
and hBD9, in contrast to the exposure of the cells to the 5
× 106 latex beads. The expression of hBD8 and hBD18 by
cells exposed to A. fumigatus was not observed in the
present study. The constitutive expression of human beta
defensin1 (hBD1) was found in the current experiment.
Since polymixin B drastically inhibits endotoxin activity,
20 μg of polymixin B per ml were added to cells before
exposure to A. fumigatus organisms in some experiments,
according to the method described by Mambula et al., in
order to rule out endotoxin contamination [27]. This had
no effect on defensin expression. Similar results were
observed for A549 cells (data not shown). Therefore,
hBD2 and hBD9 were chosen for further analysis of
defensin expression by 16HBE and A549 cells exposed to
A. fumigatus.
Role of serum in defensin expression by human 
pneumocytes and tracheal epithelial cells exposed to A. 
fumigatus
In order to investigate the potential role of the serum and
to set up the experimental conditions necessary for analys-
ing the inducible expression of defensins by the human
respiratory epithelium exposed to A. fumigatus, 16HBE
and A549 human airway epithelial cells were incubated
with A. fumigatus organisms (HF and SC or RC) or latex
beads in the presence of either 10% heterologous Fetal
Calf Serum (FCS) or 5% autologous human serum.
Expression of hBD2 and hBD9 was evaluated. As a posi-
tive control, Il-1β was used in experiments. The cells were
exposed to 106 of A. fumigatus conidia or 20 μl of A. fumi-
gatus HF solution or 5 × 106 latex beads for various periods
from 4 h to 18 h. The representative results of defensin
expression by the 16HBE cells exposed for 18 hours to A.
fumigatus are shown in Figure 2. Higher hBD2 and hBD9
gene expression was observed in the untreated control
cells and the cells exposed to the latex beads in the pres-
ence of heterologous FCS (Figure 2A), compared to the
intensity of bands corresponding to hBD2 and hBD9 in
the cells incubated in the presence of 5% autologous
human serum (Figure 2B). The treatment of the cells with
Il-1β, as well as exposure of cells to either HF or conidia of
A. fumigatus, strongly induced the expression of both
defensins by the cells incubated with human serum (Fig-
ure 2B). Similar results were observed with A549 cells. The
exposure of both types of cells to 105 conidia resulted in
defensin expression as well (data not shown).
Taking the lower basal level of defensin expression into
account in untreated control cells maintained in the
medium containing human serum compared to FCS, all
of the following experiments, unless otherwise specified,
were performed with human respiratory cells incubated in
the presence of 5% human serum.
The identities of hBD2 and hBD9 defensins were con-
firmed by direct sequencing of the products of predicted
RT-PCR analysis of various defensin expression levels in  human 16HBE epithelial bronchial cells exposed to A. fumiga- tus organisms Figure 1
RT-PCR analysis of various defensin expression levels 
in human 16HBE epithelial bronchial cells exposed to 
A. fumigatus organisms. 16HBE human epithelial tracheal 
cells (5 × 106) were grown in six well plates for 24 hours. 
After exposing the cells to RC, SC, HF or latex beads for 18 
hours, the cells were washed with PBS, mRNA was isolated 
by TRIzol Reagent and RT-PCR was performed as described 
above in Materials and Methods. Specific primer pairs (Table 
1) were used for RNA amplification: hBD1, 273 bp product; 
hBD2, 199 bp product; hBD8, 176 bp product; hBD9, 174 bp 
product; hBD18, 400 bp product and human GAPDH, which 
was used as an internal control, 473-bp product. All products 
were amplified according to the conditions described in 
Table 1. Cells were cultivated in a control well in the absence 
of A. fumigatus. As a positive control for defensin expression, 
exposure to human Il-1β was used in all experiments. The 
hBD1, hBD2 and hBD9 products were sequenced and con-
firmed to be identical to the predicted sequence. GAPDH 
was uniformly expressed. One of the four experiments is 
shown. Abbreviations: resting conidia (RC), swollen conidia 
(SC), hyphal fragments (HF), glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), interleukin-1β (Il–1β).
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molecular weight generated by PCR amplification using
upstream PCR primers.
Effect of heat inactivation of serum on inducible defensin 
expression
The mechanisms of regulation of beta defensin expression
by airway epithelial cells exposed to A. fumigatus organ-
isms are unknown; the autocrine mechanism of defensin
induction by cytokines cannot be ruled out. It was
reported that Aspergillus  induced cytokine production
whereas heat inactivation of serum decreased cytokine
production [28,29]. We therefore checked to see of the
heat-labile serum factor was required for defensin expres-
sion. To do this, human 16HBE cells were incubated
either with heterologous FCS or autologous human serum
(previously heated or not at 56°C for 30 min) and simul-
taneously exposed for 18 hours either to A. fumigatus
conidia, HF or the latex beads.
As shown in Figure 2, a high level of hBD2, as well as
hBD9 expression, was observed in the cells incubated
either with FCS (Figure 2A) or human serum (Figure 2B).
Heat inactivation of any of the serums led to the partial
decrease of the expression of both of the tested defensins
by cells exposed either to A. fumigatus conidia, HF, or to Il-
1β (Figure 2C, D).
Kinetics of defensin expression by cells exposed to A. 
fumigatus organisms
To analyse the kinetics of defensin expression, cells were
exposed to A. fumigatus for 4, 8 and 18 hours, and the
expression of hBD2 and hBD9 was examined. As a posi-
tive control, Il-1β-treated cells were examined. As a nega-
tive control, untreated cells or cells exposed to 5 × 106
latex beads were analysed as well. According to the results
presented on Figure 3, the expression of both defensins,
hBD2 and hBD9, were induced in the 16HBE cells treated
with Il-1β either for 4, 8 or 18 hours. No hBD2 expression
was detected after a 4-h exposure by 16HBE to SC, RC or
HF of A. fumigatus, in contrast to hBD9 expression by cells
exposed to all morphotypes of A. fumigatus for the same
period. Incubation of the cells with both types of conidia
or HF for 8 h resulted in a low level of hBD2 expression
and a high level of hBD9 expression, comparable to
expression by the cells treated with the positive control, Il-
1β. Exposure of the cells to conidia or HF for 18 h led to
the high expression of both defensins, hBD2 and hBD9.
Exposure of the cells to the latex beads did not induce the
defensin expression in any of the experiments. The consti-
tutive expression of hBD1 by the cells exposed either to
Table 1: Primer sequences, annealing temperatures and product size (RT-PCR).
Primers Sequences Conditions Product size
hBD1f
hBD1r
5'-agcgtctccccagttcctgaaatcct-3'
5'-tcttctggtcactcccagctcacttg-3'
38 cycles, 61°C 273 bp
hBD2f
hBD2r
5'-catcagccatgagggtcttg-3'
3'-ggctttttgcagcattttgt-3'
38 cycles, 61°C,
2.5% DMSO
199 bp
hBD8f
hBD8r
5'-tactcacctccagccttttgtcatcc-3'
5'-gggtgtagtgctctcaattcttggttg-3'
38 cycles, 61°C 176 bp
hBD9f
hBD9r
5'-tgcagtaagaggtgatttgg-3'
5'-tgacatgataagtggtgttgg-3'
32 cycles, 56°C 174 bp
hBD18f
hBD18r
5'-cctgcttcccaaggaccatgaaactc-3'
5'-ccgagaggaagtcatgagctatggtg-3'
38 cycles, 61°C 400 bp
GAPDHf
GAPDHr
5'-cccatcaccatcttccagagc-3'
5'-ccagtgagcttcccgttcagc-3'
32 cycles, 61°C 473 bp
RT-PCR analysis of defensin expression by 16HBE cells  exposed to A. fumigatus organisms in the presence of differ- ent serums Figure 2
RT-PCR analysis of defensin expression by 16HBE 
cells exposed to A. fumigatus organisms in the pres-
ence of different serums. 16HBE human epithelial bron-
chial cells (5 × 106) were grown in six well plates for 24 
hours. The cells were then exposed to the different morpho-
types of A. fumigatus or the latex beads in the presence of 
either Human (HS) or Fetal Calf Serum (FCS), (heated or not 
at 56°C). After 18 hours of incubation, the cells were washed 
with PBS, mRNA was isolated by TRIzol Reagent, and RT-
PCR was performed as described above in Materials and 
Methods. Specific primer pairs (Table 1) were used for RNA 
amplification. The sizes of amplified products are indicated 
and were as predicted. All products were amplified according 
to the conditions described in Table 1. Cells were cultivated 
in a control well in the absence of A. fumigatus. GAPDH was 
uniformly expressed. One of the four results is shown.
FCS FCS 56° C 30
HS HS 56° C 30
hBD2
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the different morphotypes of A. fumigatus or to the latex
beads for the various periods was observed in the current
experiment.
Similar kinetics of hBD2 and hBD9 expression was
observed with A549 cells (data not shown).
Real time PCR
The relative level of hBD2 and hBD9 expression in 16HBE
and A549 cells exposed to different A. fumigatus morpho-
types for 18 hours was quantified by real time PCR. The
expression of both defensins was higher in Il-1β stimu-
lated cells than in the control, as shown for 16HBE cells in
Figure 4. Exposure of 16HBE cells to SC resulted in a sta-
tistically significant increase of hBD2 and hBD9 expres-
sion compared to that of the untreated control cells or the
cells exposed to the latex beads. The increase of defensin
expression was also found in the cells exposed to RC and
HF. However, this difference was significant only for
hBD9 in the cells exposed to RC. The difference in expres-
sion of hBD2 by the cells exposed to RC and in the expres-
sion of hBD2 as well as hBD9 by the cells exposed to HF
did not reach a significant level. There was no difference
between defensin expression in the untreated control cells
and the cells exposed to the latex beads. Similar results
were obtained with A549 cells.
Neutralising anti-interleukine-1  antibody decreased 
defensin expression in cells exposed to swollen conidia
Since A. fumigatus has been shown to induce IL-1β in air-
way epithelium, and since the analysis of kinetic of
defensin expression showed that the Il-1β-induced
response was faster than the one induced by fungi (Figure
3), we investigated whether or not observed A. fumigatus-
induced defensin expression was related to Il-1 β synthe-
sized during anti-fungal response. For this reason, neutral-
ising anti-interleukine-1β antibody was added to the cells
before exposure to A. fumigatus organisms. One of the
defensins, hBD-9, was chosen for real time PCR analysis
of the role of Il-1 β in defensin expression. The results of
real time PCR revealed that relative gene expression was
statistically significantly decreased in the cells treated with
anti-Il-1 β antibody before exposure to SC, compared to
the cells only exposed to SC (120 ± 5 versus 143 ± 10
respectively). Relative gene expression was also decreased
in the cells treated with anti-Il-1 β antibody before expo-
sure to RC or HF, but the difference did not reach a statis-
tically significant level. The pre-treatment of the cells with
normal mouse immunoglobulin before exposure to A.
fumigatus organisms had no effect on defensin expression.
Analysis of defensin expression by human primary airway 
epithelial cells exposed to A. fumigatus conidia or hyphal 
fragments
To provide evidence for the biological significance of the
discovered phenomenon, we verified whether or not
inducible defensin expression was observed in the human
primary airway epithelial cells, in addition to the detected
defensin expression in airway cell lines A549 and 16HBE
(described above). Airway epithelial cells obtained from
human nasal turbinates (HNT) of patients undergoing
turbinectomy were exposed to RC, SC or HF or latex beads
for 18 hours. Examination of hBD2 or hBD9 expression
showed that both defensins were detected by RT-PCR in
the primary culture cells exposed to all of the morpho-
types of A. fumigatus (Figure 5). The relative level of hBD2
and hBD9 expression in HNT cells was quantified by real
time PCR. The expression of both defensins was higher in
Il-1β stimulated cells than in the control, as shown in Fig-
ure 6. Exposure of HNT cells to SC resulted in a statisti-
cally significant increase of hBD2 and hBD9 expression
compared to that of the untreated control cells or the cells
exposed to the latex beads. The increase of defensin
expression was also found in the cells exposed to RC and
HF. However, this difference was significant only for
hBD2 in the cells exposed to RC. The difference in expres-
sion of hBD9 by the cells exposed to RC and in the expres-
sion of hBD2 as well as hBD9 by the cells exposed to HF
did not reach a significant level. There was no difference
between defensin expression in the untreated control cells
and the cells exposed to the latex beads.
Kinetics of defensin mRNA expression by 16HBE human epi- thelial bronchial cells exposed to A. fumigatus organisms Figure 3
Kinetics of defensin mRNA expression by 16HBE 
human epithelial bronchial cells exposed to A. fumiga-
tus organisms. 16HBE human epithelial tracheal cells (5 × 
106) were grown in six well plates for 24 hours. The cells 
were then exposed to the different morphotypes of A. fumig-
atus or latex beads for the different periods: 4 h, 8 h and 18 
h. After incubation, the cells were washed with PBS, mRNA 
was isolated by TRIzol Reagent, and RT-PCR was performed 
as described above in Materials and Methods. Specific primer 
pairs and the conditions of RT-PCR are described in Table 1. 
The sizes of amplified products are indicated and were as 
predicted: hBD2, 199-bp product; hBD9, 174 bp product and 
human GAPDH, 473-bp product. The hBD2 and hBD9 prod-
ucts were sequenced and confirmed to be identical to the 
predicted sequence. Cells were cultivated in a control well in 
the absence of A. fumigatus. GAPDH was uniformly 
expressed. One of the four results is shown.
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Detection of the hBD2 peptide in human airway epithelial 
cells by immunofluorescence
To determine if defensin peptides were present in the air-
way epithelial cells exposed to A. fumigatus, the hBD2 pep-
tide was detected by immunofluorescence. Analysis of the
hBD9 peptide was not performed since anti-hBD9 anti-
bodies were not available. A549 or 16HBE cells were cul-
tured on cover slips, subsequently exposed to either SC,
RC, HF, latex beads or treated with Il-1β for 18 h, and
stained with polyclonal anti-hBD2 antibody as described
in Methods. As shown in Figure 7A, hBD2 was detected in
the cytoplasm of airway epithelial 16HBE cells exposed to
any of the morphotypes of A. fumigatus, but generally not
in the untreated control culture or in the cells exposed to
the latex beads, except for several individual cells that con-
tained some amount of defensin peptides. These findings
are consistent with the inducible expression of hBD2.
Staining revealed the punctuated distribution of peptides
in the cytoplasm with a concentration in the perinuclear
region. It should be observed that the expression of the
hBD2 peptide was not detected in each cell of the sample
exposed to A. fumigatus. Quantification of the differences
in the number of cells detected with anti-defensin-2 anti-
body showed that the number of stained cells in the
untreated control culture was 8 ± 4%. The percentage of
stained cells increased to 32 ± 4.6% after Il-1 β-treatment,
to 17 ± 4.5% after exposure to RC, to 28 ± 5.2% after expo-
sure to SC and to 20 ± 5.1% after exposure to HF, while
exposure to the latex beads did not affect defensin expres-
sion (9 ± 3.9%) (Figure 7B). Similar results were obtained
with A549 cells (data not shown).
Analysis of mRNA levels for HBD2 and HBD9 in 16HBE cells exposed to A. fumigatus organisms Figure 4
Analysis of mRNA levels for HBD2 and HBD9 in 16HBE cells exposed to A. fumigatus organisms. 16HBE cells (5 
× 106) were grown in six well plates for 24 hours. The cells were then exposed to the different morphotypes of A. fumigatus or 
latex beads for 18 h. Cells were cultivated in a control well in the absence of A. fumigatus or the latex beads. Isolation of total 
RNA and synthesis of cDNA was performed as described in Methods. Specific primer pairs and the conditions of real time PCR 
are described in Table 2. The level of mRNA for defensins was measured in total RNA preparation by quantitative real time 
PCR as described in Methods. Expression of all genes was normalised to the expression of the endogenous reference gene 
GAPDH. The expression value in control cells was used as the baseline. Data are calculated from three different experiments 
performed in triplicate. Means followed by the same letter are not significantly different.
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Co-localisation of hBD-2 and different A. fumigatus 
morphotypes
Previous experiments showed that human airway epithe-
lial cells A549 internalised A. fumigatus conidia; a phago-
cytosis rate of 30% has been reported [30]. More then
50% of internalised conidia were found to co-localise
after 24 hours with lysosomal proteins, CD63 and LAMP-
1, which revealed the maturation of late endosome into
lysosomes [31]. Similar results were obtained with pri-
mary human nasal epithelial cells. Staining of the cells
with antibody against LAMP-1 demonstrated a positive
immunofluorescence signal around digested A. fumigatus
conidia [32]. Using the method described by these
authors, we determined if different A. fumigatus morpho-
types were co-localised with intracellular hBD-2. Label-
ling A549 cells with anti-hBD-2 antibody revealed
cytoplasmic distribution of peptides. Comparison of the
image of A549 cells stained by anti-hBD-2 antibody and
the phase-contrast image revealed a positive immunoflu-
orescence signal around resting (Figure 8A, B) or swollen
(Figure 8E, F) conidia. This suggests a co-localisation of
hBD2 and digested RC or SC. In contrast, no positive
immunofluorescence signal was detected around HF,
whereas the cells were positively stained with anti-human
hBD2 antibody (Figure 8I, J). The normal rabbit serum
control labels neither cytoplasm nor A. fumigatus mor-
photypes (Figure 8C, D, G, H, K, L). Similar results were
obtained with 16 HBE cells.
Quantification of hBD2 in cells supernatants by sandwich 
ELISA
In order determine if synthesized hBD2 was released to
cell supernatants, the level of hBD2 in the supernatants of
16HBE, A549 and HNT primary culture cells was evalu-
ated by sandwich-ELISA. As shown in Figure 9, 140, 150
and 100 pg/ml of hBD2 were detected in the supernatants
of Il-1β-treated 16HBE, HNT and A549 cells, respectively.
Comparable levels of hBD2 were detected in the superna-
tants of all cells exposed to SC: 100, 180 and 70 pg/ml
were found in the supernatants of 16HBE, HNT and A549
cells, respectively, which was statistically significantly
higher then hBD2 levels in the supernatants of the cells
alone or the cells exposed to RC, HF or latex beads. Expo-
sure of any cells to RC or HF resulted in lower levels of
hBD2, ranging from 20 to 70 pg/ml. The difference
between hBD2 levels in the supernatants of the cells
exposed to either RC, or those exposed to latex beads, was
statistically significant for HNT cells, while this difference
did not reach statistically a significant level for A549 and
16HBE cells. This could be explained by the different reac-
tions of the different kinds of cells to the pathogen. The
difference between hBD2 levels in the supernatants of
16HBE, HNT and A549 cells exposed to either RC, or
those exposed to latex beads, was statistically insignifi-
cant.
Analysis of hBD2 expression by airway epithelial cells 
exposed to live A. fumigatus
In order to determine if hBD2 expression was induced in
the respiratory cells by live A. fumigatus organisms, RT-
PCR and immunofluorescence analysis of cells exposed to
unfixed 106 live conidia was performed. Using micro-
scopic observation, we first examined the development of
A. fumigatus in the environment of the epithelial A549 or
16HBE cells. When the RC were added to the epithelial
cells, they settled onto the cells within 30 minutes and
began to swell after 3–4 hours; after 8 hours of infection,
the SC became polarised and began to germinate. The
germ tubes then progressively elongated, forming the
hyphae: after 18 hours of infection, the hyphae had com-
pletely covered the epithelial cells (data not shown).
RT-PCR analysis of the A549 cells exposed to live A. fumi-
gatus RC for 4, 8 and 18 hours allows us to detect hBD2
expression after 18 hours of incubation (Figure 10A),
whereas no inducible hBD2 expression was observed after
4 or 8 hours of incubation (data not shown). Treatment of
A549 cells either with IL-1 β or TNF-α for 18 hours
RT-PCR analysis of defensin mRNA expression by primary  epithelial cells Figure 5
RT-PCR analysis of defensin mRNA expression by 
primary epithelial cells. Primary epithelial cells were 
obtained from human nasal turbinates (HNT), as described in 
Methods. The cells (5 × 106) were grown in the six well 
plates for 48 hours. The cells were then exposed to either 
the latex beads or A. fumigatus organisms for 18 hours. The 
mRNA was then isolated by TRIzol Reagent and RT-PCR was 
performed as described above in Materials and Methods. 
Specific primer pairs (Table 1) were used for RNA amplifica-
tion. The sizes of amplified products are indicated and were 
as predicted. The hBD2 and hBD9 products were sequenced 
and confirmed to be identical to the predicted sequence. 
GAPDH was uniformly expressed. Cells in a control well 
were cultivated in the absence of A. fumigatus. One of the 
three results is shown.
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resulted in the inducible hBD2 expression. Detection of
hBD2 in epithelial cells exposed to live A. fumigatus
conidia for 18 hours by the immunofluorescence method
revealed punctuated distribution of peptides in the cyto-
plasm with a concentration in the perinuclear region, sim-
ilar to the staining of hBD2 in cells exposed to ethanol-
fixed conidia or HF (Figure 10C). Several individual cells
were stained with anti-hBD2 antibody in the untreated
control cells or in cells exposed to the latex beads. Quan-
tification of cells stained with hBD antibody revealed the
increase in the number of stained cells from 6 ± 4.8% in
the untreated control cells to 32 ± 5.7% in the IL-1β-
treated culture, to 19 ± 6% in TNF-treated culture and to
35 ± 4.7% in the cells exposed to live A. fumigatus, com-
pared to 8 ± 4% cells in the culture exposed to 5 × 106 latex
beads (Figure 10B).
Transcriptional and post-transcriptional mechanisms of 
defensin expression regulation
In order to determine if the observed increase of defensin
(hBD2 and hBD9) expression by cells exposed to A. fumi-
gatus was related to transcriptional activation or enhanced
stabilisation of mRNA, 16HBE cells were pre-treated with
0.5 μg of actinomycin D (an inhibitor of RNA transcrip-
tion) per ml, or DMSO (vehicle control), 1 h before expo-
sure of the cell to conidia or HF for an additional 8 or18
Analysis of mRNA levels for HBD2 and HBD9 in HNT primary culture cells exposed to A. fumigatus organisms Figure 6
Analysis of mRNA levels for HBD2 and HBD9 in HNT primary culture cells exposed to A. fumigatus organisms. 
Primary epithelial HNT cells (5 × 106) were grown in six well plates for 48 hours. The cells were then exposed to the different 
morphotypes of A. fumigatus or latex beads for 18 h. Cells were cultivated in a control well in the absence of A. fumigatus or the 
latex beads. Isolation of total RNA and synthesis of cDNA was performed as described in Methods. Specific primer pairs and 
the conditions of real time PCR are described in Table 2. The level of mRNA for defensins was measured in total RNA prepa-
ration by quantitative real time PCR as described in Methods. Expression of all genes was normalised to the expression of the 
endogenous reference gene GAPDH. The expression value in control cells was used as the baseline. Means followed by the 
same letter are not significantly different.
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h, as described in the literature [33]. The viability of
16HBE cells and total RNA yield were verified after each
treatment, and there was no difference between treated
and untreated control cells. As shown in Figure 11, expo-
sure of the 16HBE cells either to DMSO or Act D resulted
in almost no increase of defensin expression compared to
control cells, while the expression of both defensins by
the 16HBE cells exposed to the various forms of A. fumig-
atus conidia for either 8 or 18 h was inhibited by the pre-
treatment of cells with Act D. Therefore, the data indicated
that new gene transcription is required for hBD2 and
hBD9 expression by cells exposed to A. fumigatus RC, SC
or HF.
To determine if the increase in defensin mRNA expression
was dependent on protein synthesis, 16HBE cells were
pre-treated with 2.5 μg of cycloheximide (CHX), a protein
synthesis inhibitor, 1 h before exposure to A. fumigatus.
Pre-treatment of the cells with only CXH did not change
defensin expression, compared to control cells. In con-
trast, pre-treatment of 16HBE cells with CXH resulted in
the inhibition of defensin expression after exposure to A.
fumigatus (Figure 12). Therefore, it could be hypothesized
that protein synthesis might be required for induced accu-
mulation of defensin mRNA.
Discussion
A better understanding of the mechanisms responsible for
the defence against invasive Aspergillus  infection is
required to develop strategies aimed at boosting the anti-
fungal actions of the immune system. Defensins, or anti-
microbial peptides, which are implicated in potentiating
Localisation of the hBD2 peptide in epithelial bronchial 16HBE cells Figure 7
Localisation of the hBD2 peptide in epithelial bronchial 16HBE cells. 16HBE cells were seeded at 5 × 105 cells per 
well in 1 ml of DMEM/F12 on 18-mm-diameter cover slips in 12 well plates in triplicate and grown for 16 h at 37°C. After 
washing the cover slips with PBS-BSA, the cells were exposed to either latex beads, ethanol fixed conidia or ethanol fixed HF 
for 18 hours. Il-1β was used as a positive control. Following washing with PBS, the cells were fixed with a paraformaldehyde 
solution for 30 min at 37°C. The slides were then incubated in 1% BSA/PBS-Triton 0.05%, followed by a solution of 10% nor-
mal goat serum. After washing, polyclonal rabbit anti-human hBD2 at a dilution of 1:250 was applied as primary antibody over-
night at 4°C, followed by incubation with FITC-labelled goat anti-rabbit secondary antibody at a dilution of 1:300 for 4 hours at 
room temperature. After washing, the cover slips were mounted on slides with ProLong antifade Vectashield. Samples were 
viewed with a Zeiss fluorescence microscope using ×400 magnification. The arrows indicate the cells stained with anti-hBD2 
antibody. The percentage of stained cells was computed from triplicates of four experiments. Means followed by the same let-
ter are not significantly different. +, presence; -, absence of Il-1β, A. fumigatus fixed organisms and latex beads. The punctuated 
localisation of the signal, which is concentrated adjacent to the nucleus (arrow), was observed. The data shown are represent-
ative of four independent experiments.
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innate and adaptive immunity [16-18] in addition to
direct antimicrobial activities [20], would be a good can-
didate as a therapeutic agent for enhancing host defence
mechanisms. Since the invasion of the airway epithelium
by A. fumigatus conidia may play an important role in the
development of aspergillosis, we therefore investigated
the involvement of defensins in the response of pneumo-
cytes A549 and bronchial epithelial cells 16HBE exposed
to A. fumigatus in this study. The expression of human
defensins hBD1, hBD2, hBD8, hBD9 and hBD18 was ana-
lysed. In agreement with earlier findings [34], constitutive
expression of hBD1 by the epithelial cells 16HBE and
A549 was observed in our experiments. It was found that
hBD2 and hBD9 are highly expressed by the epithelial res-
piratory cells exposed to SC, RC or HF of A. fumigatus,
while hBD8 and hBD18 gene expression was not observed
in the current study. Previous investigations revealed that
hBD2 was induced by various stimuli including microbes,
cytokines and growth factors [33,35]. Inducible expres-
sion of hBD2 defensins by airway epithelial cells exposed
to A. fumigatus, observed in the present work, is therefore
in agreement with earlier observations. The role of the
recently discovered hBD9 in innate antimicrobial defence
is not well determined; however, hBD9 gene regulation in
gingival keratinocytes exposed to Candida albicans has
been described [36]. Additional investigations are essen-
Co-localisation of hBD2 and A. fumigatus organisms Figure 8
Co-localisation of hBD2 and A. fumigatus organisms. A549 cells were grown on cover slips for 16 h at 37°C. Cells were 
exposed to RC (A, B, C, D), SC (E, F, G, H) or HF (I, J, K, L) for 18 hours at 37°C. After fixation and permeabilisation, as 
described for Figure 7, cells were labelled with specific anti-hBD-2 antibody (A, B, E, F, I, J) and secondary antibody conjugated 
to Texas-red. Normal rabbit serum was used instead of anti-hBD2 as a negative control (C, D, G, H, K, L). Immunofluores-
cence signal (A, E, I, C, G, K) was compared to phase contrast image of the same cells (B, F, G, D, H, L). Arrows indicated dif-
ferent A. fumigatus morphotypes.
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tial for a better understanding of its role in direct antimi-
crobial activity and its contribution to innate immunity.
The role of hBD8 and hBD18 in innate immunity of res-
piratory epithelium exposed to A. fumigatus cannot be
ruled out before evaluation of other epithelial respiratory
cells or other induction conditions. Further analysis of
those defensins is recommended.
We have shown that the maintenance of the human epi-
thelial cells in the presence of preheated serum (56°C for
30 min) resulted in the partial decrease of defensin expres-
sion. Involvement of the heat-labile serum factor suggests
the potential role of the complement for defensin expres-
sion. The possible link between the proteins of the com-
plement system and defensin expression may be
anticipated since the interaction between the defensins
and proteins of the complement system was demon-
strated. It was found that HBD2 inhibits the classical path-
way of the complement system [37]. Moreover, the
interrelationship between the respiratory tract and the
complement system was studied in an animal model [38].
The origin of complement proteins present in the lining
fluid of the respiratory tract is thought to result mainly
from plasma that exudes into the bronchoalveolar space.
However, it was shown that human bronchial epithelial
cells generate complement protein C3: the modulation of
its expression by proinflammatory cytokines might be an
additional regulatory mechanism of local airway defence
during infection [39].
Furthermore, the kinetics of the expression of human beta
defensins, hBD2 and hBD9, by airway epithelial cells
exposed to the deferent morphotypes of A. fumigatus was
analysed. Analysis of the kinetics of hBD2 and hBD9
defensin expression by cells exposed to A. fumigatus
showed the prompt inducible expression of hBD9, fol-
lowing by delayed hBD2 expression. This could allow us
to hypothesize that the host immune system may react
against A. fumigatus by using the cascade of newly synthe-
sized defensins that probably possess the different func-
tions. However, this hypothesis would require further
investigation at the protein level. Our data are in agree-
ment with the analysis of kinetics of hBD2 expression by
A549 cells exposed to Mycobacterium tuberculosis; infection
of A549 cells resulted in hBD2 gene expression as early as
6 hours postinfection, while maximum expression was
detected at 18 and 24 hours postinfection [35].
Several lines of evidence eliminated the possibility that
observed inducible defensin expression was related to
endotoxin contamination of A. fumigatus organisms. First,
the addition of Polymixin B (known for its endotoxin-
neutralising activity) to the cells prior to exposure to A.
fumigatus organisms did not have any effect on defensin
expression. Second, rigorous measures were undertaken
to keep endotoxin out of the experimental system, includ-
ing washing of A. fumigatus organisms with the solution
containing Polymixin B during preparation, utilisation of
endotoxin-free plasticware and solutions in experiments,
and washing of fungal organisms in endotoxin-free PBS
prior to use.
The expression of hBD2 and hBD9 was found to be higher
in A549, 16HBE and primary culture HNT cells exposed to
SC compared to RC or HF, as shown by quantitative PCR.
During asexual growth, the morphological form of A.
fumigatus changes from resting to swollen conidia, which
then form germ tubes that continue growing in hyphal
form. These transformations are accompanied by the
modification of surface structures. The RC are covered
with a proteinoceous layer that is disrupted during swell-
ing, exposing the inner layer. Therefore, the surfaces of
Analysis of hBD2 level in cell supernatants Figure 9
Analysis of hBD2 level in cell supernatants. The level of 
hBD2 in supernatants of 16HBE, A549 and primary culture 
HNT cells was measured by sandwich-ELISA. Briefly, cells 
were grown and exposed to different A. fumigatus organisms, 
latex beads or Il-1β (positive control) for 18 hours at 37°C. 
Supernatants were collected as described in Methods. The 
level of hBD was computed from duplicates of three experi-
ments. Means followed by the same letter are not signifi-
cantly different.
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Analysis of the defensin expression and its localisation in pneumocytes A549 exposed to live A. fumigatus Figure 10
Analysis of the defensin expression and its localisation in pneumocytes A549 exposed to live A. fumigatus. A. 
RT-PCR analysis of defensin mRNA expression by human pneumocyte A549 cells exposed to live A. fumigatus. A549 human 
epithelial bronchial cells (5 × 106) were grown in six well plates for 24 hours. The cells were then exposed either to live A. 
fumigatus conidia or latex beads. After 18 hours of incubation, the cells were washed with PBS, mRNA was isolated by TRIzol 
Reagent, and RT-PCR was performed as described above in Methods. Specific primer pairs (Table 1) were used for RNA ampli-
fication. The size of the amplified product is indicated and was as predicted. Cells were cultivated in a control well in the 
absence of A. fumigatus. As an additional control, the cells were exposed to 106 latex beads for the same period. GAPDH was 
uniformly expressed. One of the four results is shown. B. Immunofluorescence detection of hBD2 in the A549 exposed to live 
A. fumigatus conidia. A549 cells were seeded at 5 × 105 cells per well in 1 ml of DMEM/F12 on 18-mm-diameter cover slips in 
12 well plates in triplicate and grown for 16 h at 37°C. After washing the cover slips with 1%BSA/PBS, the cells were exposed 
to either latex beads or live A. fumigatus conidia for 18 hours. Il-1β was used as a positive control. Some cells were treated with 
TNF-α. Following washing with PBS, the cells were fixed with a paraformaldehyde solution for 30 min at 37°C. The slides were 
then incubated in 1% BSA/PBS, followed by a solution of 10% normal goat serum. After washing, polyclonal rabbit anti-human 
hBD2 at a dilution of 1:250 was applied as primary antibody overnight at 4°C, followed by incubation with FITC-labelled goat 
anti-rabbit secondary antibody at a dilution of 1:300 for 4 hours at room temperature. After washing, the cover slips were 
mounted on slides with ProLong antifade Vectashield. Samples were viewed with a Zeiss fluorescence microscope using ×400 
magnification. The arrows indicate the cells stained with anti-hBD2 antibody. The percentage of stained cells was computed 
from triplicates of four experiments. Means followed by the same letter are not significantly different. +, presence; -, absence of 
Il-1β, TNF-α, live A. fumigatus organism and latex beads. The punctuated localisation of the signal, which is concentrated adja-
cent to the nucleus (arrow), was observed. The data shown are representative of four independent experiments.
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various A. fumigatus morphotypes differ form each other
and, consequently, the reaction of host cells may vary
towards divergent A. fumigatus growth forms [40]. Our
findings suggest that infected hosts can discriminate
between inactive RC and active potentially-invasive SC.
The data are consistent with findings showing that SC (the
mature form of A. fumigatus), but not RC-activated NF-kβ,
stimulated pro-inflammatory cytokines and the produc-
tion of reactive oxygen by host macrophages [40].
Moreover, the presence of the hBD2 peptide in the respi-
ratory cells was investigated. Detection of the hBD2 pep-
tide by immunofluorescence in A549 and 16HBE cells
exposed to the different forms of A. fumigatus confirmed
its inducible expression in the infected cells. The presence
of the negatively-stained cells in the infected culture may
be due to defensin synthesis in the subpopulation of the
epithelial cells or because of the release of synthesized
defensins by the activated cells. The detection of the beta-
defensin hBD2 peptide in the individual unstimulated
control cells is in agreement with the observation made
for the alpha-defensins; it has been reported that individ-
ual untreated HL-60 cells may contain variable amounts
of alpha defensin, as assessed by immunostaining [41].
Undoubtedly, inducible expression of defensin by cells
exposed to A. fumigatus may represent the recruitment of
additional cells that would synthesize antimicrobial pep-
tides and further upregulation of defensin synthesis in
cells that originally contained defensin. Punctuated distri-
bution of peptide in the cytoplasm of A549 and 16HBE
cells with a concentration in the perinuclear region was
similar to the staining of defensin expressed by human
gingival epithelial cells exposed to cell wall extract of the
gram-negative periodontal bacteria, Fusobacterium nuclea-
tum  [33], suggesting that the mechanism of defensin
expression may be universal for the different infectious
agents. The punctuated perinuclear pattern of immunos-
taining may be related to the localisation of hBD2 in the
endoplasmic reticulum and Golgi apparatus, which is in
agreement with the previous observations of Rahman et
al., showing that the hBD2 peptide was expressed in
rough endoplasmic reticulum, the Golgi complex and
cytoplasmic vesicles of human colon plasma cells [42].
Quantification of the cells stained with anti-hBD2 anti-
body revealed that SC induced a greater number of cells
that synthesized hBD2, compared to RC and HF. Analysis
Effect of RNA synthesis inhibition on inducible defensin  expression Figure 11
Effect of RNA synthesis inhibition on inducible 
defensin expression. 16HBE human epithelial bronchial 
cells (5 × 106) were grown in six well plates for 24 hours. 
The cells were then pre-treated with 1 mg of actinomycin D/
ml (ActD) or DMSO solvent for 1 h, and some samples were 
then exposed to the different morphotypes of A. fumigatus 
either for 6 (Figure 7A) or for 18 (Figure 7B) hours. There 
was no significant difference in viability between control and 
treated cells as assessed by staining with trypan blue. Fur-
thermore, the yields of total RNA from the samples were 
compared and showed no difference. Total RNA was 
extracted and analysed by RT-PCR. The sizes of amplified 
products are indicated and were as predicted. GAPDH was 
uniformly expressed. Complete inhibition of hBD2 and hBD9 
expression by the cells exposed to A. fumigatus, either for 6 
or for 18 hours was observed after pre-treatment of the cells 
with actinomycin D.
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Effect of protein synthesis inhibition on inducible defensin  expression Figure 12
Effect of protein synthesis inhibition on inducible 
defensin expression. 16HBE human epithelial tracheal cells 
(5 × 106) were grown in six well plates for 24 hours. The 
cells were then pre-treated with 2.5 μg of cycloheximide 
(CHX) for 1 h, and some samples were then exposed to the 
different morphotypes of A. fumigatus, either for 6 (Figure 
8A) or for 18 (Figure 8B) hours. There was no significant dif-
ference in viability between control and treated cells as 
assessed by staining with trypan blue. Furthermore, the yields 
of total RNA from the samples were compared and showed 
no difference. Total RNA was extracted and analysed by RT-
PCR. The sizes of amplified products are indicated and were 
as predicted. GAPDH was uniformly expressed. Complete 
inhibition of hBD2 and hBD9 expression by the cells exposed 
to A. fumigatus either for 6 or for 18 hours was observed 
after pre-treatment of the cells with cycloheximide.
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of hBD2 levels in the supernatants of A549, 16 HBE and
primary culture HNT cells confirmed this observation; sig-
nificantly higher hBD2 levels were detected in all tested
cell supernatants exposed to SC, compared to those
exposed to RC, HF or latex beads. The level of hBD2
detected in the cell supernatants does not exceed 200 pg/
ml and was comparable to the level of hBD2 in cell super-
natants exposed to other pathogens [43]. Since Okamoto
et al. showed that the effective dose of synthetic hBD2 was
1.5 μg/ml, we can hypothesize that the chemotactic activ-
ity of hBD2 rather then its direct antifungal activity plays
a more important role in the protection of the infected
host [20]. However, antifungal activity of defensins in
synergy with other antifungal factors in vivo cannot be
excluded.
Co-localisation analysis of hBD2 and A. fumigatus mor-
photypes allow us to detect RC or SC stained with hBD2
antibody in contrast to HF; these observations confirm the
different mechanism of hBD2 induction by various mor-
photypes. Our findings are in agreement with the observa-
tions of Lopez Bezzera et al. who found that A. fumigatus
conidia and hyphae injure endothelial cells via different
mechanisms [44]. This difference between the different
growth phases of A. fumigatus could be due to the discrep-
ancy of the mechanisms of defensin induction, which
may possibly be related to the diverse types/numbers of
molecules involved in this process. Immunofluorescence
analysis of inducible hBD2 expression by cells exposed to
live A. fumigatus organisms revealed the perinuclear stain-
ing of peptide, similar to the staining observed in cells
exposed to fixed A. fumigatus, pointing to the biological
significance of our findings. Given the fact that conidia
germinate and form hyphae after epithelial cells are
exposed to live A. fumigatus conidia for 18 hours, in agree-
ment with previous observation [44], we can then hypoth-
esize that defensin expression is possibly induced by
different morphotypes in this experiment.
Our observations of the induced defensin expression in
the airway epithelial cells treated with Il-1 β or TNF-α, the
cytokines that play an important role during Aspergillus
infection [45,46], suggest that defensin expression in
infected cells may be induced by A. fumigatus organisms,
as well as by the cytokines involved in the infectious proc-
ess. Therefore, the regulation of defensin expression dur-
ing Aspergillus infection may possibly depend on a variety
of factors.
Significant decrease of defensin expression by neutralising
anti-IL-1β antibody, added to the cells prior exposure to
SC, reflects the autocrine mechanism of defensin induc-
tion. A statistically insignificant decrease of defensin
expression in the cells treated with anti-IL-1β antibody
and exposed to RC or HF supported the hypothesis that
the host immune system may distinguish and react differ-
ently towards divers Aspergillus morphotypes.
Finally, to better understand defensin synthesis, we inves-
tigated the involvement of transcriptional and post-tran-
scriptional mechanisms in the regulation of defensin
synthesis. The inducible expression of hBD2 and hBD9 by
cells exposed to all morphotypes of A. fumigatus was
inhibited by pre-treatment with actinomycin D, implying
that defensin genes are regulated at the transcriptional
level. The inhibitory effect of cycloheximide on defensin
induction substantiates the requirement for new protein
synthesis, which may include cell receptors, transcription
factors or proteins that enhance mRNA stability. Thus,
post-transcriptional mechanisms of regulation were
involved in the inducible expression of defensins as well.
Conclusion
While the direct fungicidal activity of hBD2 against A.
fumigatus was revealed in the in vitro model [20], this is the
first study, according to our knowledge, showing hBD2
and hBD9 defensin expression by host airway epithelial
cells exposed to A. fumigatus. Defensin expression was
higher in the cells exposed to SC than to RC or HF. More-
over, the HBD2 level was elevated in the supernatants of
cells exposed to SC, compared to other Aspergillus mor-
photypes. Our findings suggest that identification of the
most invasive fungal form by the host may be beneficial
for anti-fungal host response.
Autocrine regulation of defensin expression in cells
exposed to A. fumigatus was established in the experi-
ments with neutralising anti-Il-1β antibody. Investigation
of defensin expression at transcriptional and post-tran-
scriptional level demonstrated the requirement of tran-
scription as well as new protein synthesis during A.
fumigatus  defensin induction. The presence of defensin
peptide hBD2 was revealed using immunofluorescence
that showed a punctual cytoplasmic and perinuclear
staining, suggestive of endoplasmic reticulum and Golgi
apparatus localisation. The discovery of inducible hBD2
and hBD9 defensin expression by human primary respira-
tory culture cells is indicative of the biological significance
of the observation. Our finding provides evidence that res-
piratory epithelium might play an important role in the
early immune response during Aspergillus infection. Tak-
ing the antimicrobial activity of defensins together with
their capacity to induce the migration of cells involved in
the immune response into account, we can hypothesize
that defensins may link innate and acquired immunities
of the host infected by A. fumigatus. Future study of the
regulation of defensin expression might provide new
approaches that may enhance expression of antimicrobial
peptides for potential therapeutic use during aspergillosis
treatment.BMC Microbiology 2009, 9:33 http://www.biomedcentral.com/1471-2180/9/33
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Methods
Reagents
Human serum, actinomycin D and cycloheximide were
obtained from Sigma. Actinomycin D and cycloheximide
were dissolved in dimethyl sulfoxide (DMSO) (Sigma). In
all the experiments, the concentration of DMSO was
always less than 0.1% (vol/vol). Interleukun-1β (Il-1 β)
was purchased from Sigma. Lyophilised powder of Il-1β
was reconstituted to the stock concentration of 10 μg/ml
with sterile phosphate buffered saline (GIBCO BRL).
Twenty ng/ml of IL-1β solution was used as a positive con-
trol for defensin expression in all experiments. Mono-
clonal anti human Il-1 β antibody (I3642) were obtained
from Sigma. Recombinant human Tumor Necrosis Factor
alpha (TNF-α) was obtained from Sigma; 10 ng/ml of TNF
solution was used in the experiments.
Anti-hBD-2 polyclonal antibody was purchased from Pep-
tide International, Inc (Louisville, Kentucky, USA).
Lyophilised powder of anti-hBD-2 antibody was reconsti-
tuted to the stock concentration of 10 mg/ml with sterile
phosphate buffered saline (GIBCO BRL). Bronchial epi-
thelium medium (BEGM) was obtained from Lonza
Group Ltd (Basel, Switzerland).
Maintenance of endotoxin-free conditions
Experiments were designed to minimise endotoxin con-
tamination by using purchased endotoxin-free plas-
ticware and heating all glassware at 180°C for 4 hours. All
solutions used in the experiments contained less then
0.007 endotoxin unit/ml (minimal detectable level) when
tested with Limulus amebocyte lysate assay (Sigma). A.
fumigatus organisms were washed in the solution contain-
ing Polymixin B during preparation.
Patient material
Human nasal turbinates of patients undergoing turbinec-
tomy (Pr. G. Lamas, La Pitié-Salpêtrière University Hospi-
tal Centre, Paris, France) were used for the preparation of
the primary epithelial cells. All patients signed an
informed consent form before participating in this
research protocol, which was approved by the Institu-
tional Ethics Committee.
Fungal strain and growth conditions
The A. fumigatus  strain, CBS 144.89 (Institut Pasteur,
Paris, France), was used throughout this study. A. fumiga-
tus conidia were prepared as previously described [22].
Briefly, conidia of A. fumigatus were obtained from cul-
tures grown on YM agar (0.3% yeast extract, 2% malt
extract, 0.5% peptone and 0.5% agar) for three days at
37°C. Conidia were harvested by flooding the plates with
sterile distilled water and then suspending the hydropho-
bic conidia in 0.01% Tween 20 in phosphate-buffered
solution (PBS). To remove hyphae and debris, the conid-
ial suspension was filtered through four levels of gauze.
The RC obtained were maintained at 4°C.
Preparation of swollen conidia and hyphal fragments
SC were prepared as described [47]. Briefly, 5 × 109 of rest-
ing A. fumigatus conidia were incubated in 200 ml of Sab-
ouraud medium for 5 hours at 37°C in order to obtain the
isodiametric swelling of the conidium resulting in the
development of SC. As demonstrated by microscopic
examination, the majority of the organisms were single
conidia, with a few small clumps containing two to four
organisms. To obtain a homogeneous preparation, the
suspension was gently sonicated for 10 seconds using a
Branson Sonifier 450 (output level 2; Branson Ultrason-
ics, Danbury, CT, USA). Before exposure of the cells to
conidia, the solution was vigorously vortexed and
observed microscopically to ensure the absence of
clumps.
Hyphal fragments (HF) were prepared by incubating 2 ×
108 of resting conidium in 200 ml of Sabouraud medium
for 18 hours at 37°C with shaking in order to obtain a
homogenous solution of the small HF. The tubes were
then centrifuged in order to spin down the pellet. For the
purpose of standardising the hyphal inoculum by weight,
the pellet, which almost exclusively contained mycelium,
was washed twice with Hanks balanced saline solution
without Ca2+ and Mg2+ (HBSS w/o), followed by filtra-
tion through the gauze that was weighed beforehand. The
gauze containing HF was dehydrated at 60°C overnight
and weighed [29]. The difference between the weight of
the gauze alone and the gauze containing the dry myc-
elium corresponds to the weight of the dry mycelium. 700
mg of dry weight of mycelial mass was obtained during
experiments under the conditions described above.
Twenty ml of PBS were then added to the dry mycelial
mass and vigorously resuspended. All A. fumigatus mor-
photypes were prepared so as to minimise endotoxin con-
tamination as described [27]. To eliminate potential
endotoxin contamination, RC, SC or HF were washed in
PBS containing 50 μg/ml of Polymixin B, known for its
capacity to drastically decrease endotoxin activity, fol-
lowed by four additional washings in endotoxin-free PBS.
Since human cells have to be exposed to the different
forms of A. fumigatus for various periods of time (includ-
ing 18 hours to allow the RC to germinate), all A. fumiga-
tus  morphotypes were fixed in ethanol. The different
solutions, containing RC, SC or HF, were centrifuged and
resuspended in a 70% solution of ethanol in PBS and
stored in a refrigerator for 24 hours as described in the lit-
erature [29]. After centrifugation, either conidium or HF
were vigorously resuspended in PBS containing 10 mg of
RNAse A per ml (Sigma Aldrich) and incubated for 30 min
at 37°C to remove intracellular RNA [29]. After several
washings in PBS, the different forms of A. fumigatus wereBMC Microbiology 2009, 9:33 http://www.biomedcentral.com/1471-2180/9/33
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viewed under the microscope; homogeneous solutions
containing single resting or SC were obtained. The mor-
phology of the mycelium was not altered. After being
fixed in ethanol, mycelia (700 mg of dry weight in 20 ml
of PBS) were used as a standard HF solution. In experi-
ments with ethanol-fixed A. fumigatus organisms, the
equivalent volume of the supernatant from the last wash-
ing was added to the human cells to check for the release
of any toxic material as a result of the ethanol treatment.
There was no induction of the defensin expression in the
cell culture incubated in the presence of the supernatants
from the last washing.
Human cell lines and growth conditions
A type II pneumocyte cell line A549 derived from a
human lung carcinoma was obtained from the American
Type Culture Collection [ATCC CCL 185 [48]] and main-
tained in Kaighn's modification of HAM's F12 medium
supplemented with 10% FCS (Invitrogen, Cergy Pontoise,
France), pen/strep (16 mg/ml penicillin and 100 mg/l
streptomycin), 2 mM L-glutamine and 1.5 g/l sodium
bicarbonate. The cells were grown until confluent at 37°C
in an incubator with a humidified atmosphere of 5%
CO2. Trypsin/EDTA (Invitrogen) was used to release
adherent cells for subculturing when this was required.
Human bronchial epithelial SV40-transformed cells
(16HBE) were kindly provided by Dr. D.C. Gruenert
(Research Facility, California Pacific Medical Center, San
Francisco, CA, USA). 16HBE cells were maintained in
DMEM/F12 medium (Invitrogen) with 10% FCS (Invitro-
gen), pen 100 U/ml/strep 100 μg/ml, 2 mM L-glutamine
(Sigma) and 1 Ug/ml de fungizone and 1.5 g/l sodium
bicarbonate (Sigma), and were grown until confluent
[49].
Establishment and maintenance of human airway 
epithelial primary culture cells
Primary epithelial cells were obtained from human nasal
turbinates (HNT) of patients undergoing turbinectomy as
previously described [50]. Briefly, HNT were washed in
Dulbecco's modified Eagle medium DMEM/F12 (Invitro-
gen) and incubated with 2 mg/ml pronase (Protease XIV;
Sigma,) in DMEM/F12 supplemented with pen/strep, at
4°C for 16–20 h under slow rotary agitation (80 rpm.).
After washing, aggregates were discarded and dissociated
cells were filtered using a 30-μm pore filter. The cell sus-
pension was then plated for 2 h at 37°C on plastic dishes
(Falcon) to eliminate contaminating fibroblasts. After
centrifugation, the supernatant containing the epithelial
cells was cultivated in a 1:1 mix (vol:vol) of bronchial epi-
thelium medium BEGM (Lonza Ltd): DMEM/F12 supple-
mented with Clonetics singlequots (5 μg/mL insulin, 0.5
μg/mL hydrocortisone, 0.5 μg/mL epinephrine, 6.5 ng/
mL triiodothyronine, 10 μg/mL transferrin, 0.5 ng/mL
human epidermal growth factor, 50 μg/mL gentamicin-
amphotericinB, 0.13 mg/mL bovine pituitary extract), 50
U/mL of penicillin-streptomycin and 0.5% fungizone.
Heat inactivation of the serum
In the experiments devoted to the investigation of the role
of the heat-labile component of serum in the production
of defensins by the human airway epithelium, heat inacti-
vation of the serum, the recognised method for serum
decomplementation, was performed as described [51].
Briefly, either human autologous serum or heterologous
FCS was heated at 56°C for 30 min. After cultivation of
the human respiratory cells under the conditions
described above, the cells were exposed to A. fumigatus in
the medium containing serum that was either heat-inacti-
vated or not.
Exposure of the cells to A. fumigatus conidia or hyphal 
fragments
5 × 106 of A549, 16HBE or primary culture cells were
placed in six well plates in 1.5 ml of the corresponding
medium described above and grown until confluence.
Following washing of A549, 16HBE or primary culture
cells with PBS, 106 of A. fumigatus conidia per millilitre of
medium were added to the cells for 4, 8 or 18 hours. Expo-
sure to HF was carried out by incubation of the cells for 4,
8 or 18 hours with 20 μl of the standard solution (35 mg
of dry weight/ml) obtained from 2 × 108 of resting conid-
ium as described above. All A. fumigatus morphotypes
were washed an additional four times in endotoxin-free
PBS prior to use to eliminate potential endotoxin contam-
ination.
After incubation, unbound conidia were removed by
washing wells with PBS prior to RNA purification.
Primary epithelial cells were seeded at 5 × 106 cells per
well and grown for 48 h before exposure to A. fumigatus.
In some experiments, the cells were exposed to 106
unfixed live conidia for 18 hours.
To be sure that the inducible expression of defensins was
specific to A. fumigatus and did not simply reflect a phago-
cytosis response, latex beads were used as a control, since
it was shown that the respiratory cells are capable of inter-
nalising nonspecific particles such as latex beads [52].
Compared to the concentration of conidia, up to a five-
fold higher concentration of latex beads was used in the
experiments, as suggested [30].
Before exposing the cells to the A. fumigatus organisms,
the solutions were vigorously vortexed and observed
microscopically to ensure that they did not contain
clumps.BMC Microbiology 2009, 9:33 http://www.biomedcentral.com/1471-2180/9/33
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RNA isolation and analysis of defensin expression by RT-
PCR
In order to ensure that the cells were exposed to different
morphotypes of A. fumigatus organisms (conidia or HF)
during the incubation period, the cell culture was
observed microscopically at the beginning and at the end
of the exposure. The medium was discarded, the wells
were briefly washed with PBS solution, and TRIzol reagent
was added to the cells.
Total RNA was isolated with TRIzol Reagent (Invitrogen,
Cat N 15596-026) according to the manufacturer's
instructions. RNA was precipitated with ethanol and
resuspended in diethyl pyrocarbonate H20. The RNA con-
centration was measured by spectroscopy, and the integ-
rity of RNA was assessed on an agarose gel. cDNA was
synthesized from 1 μg of purified RNA, using 50 nM of
Oligo dT, 16 mer, (Operon Biotechnologies SP230), 30
units of AMV Reverse Transcriptase (Promega M5108)
and RNA-se free H20 in a reaction volume of 25 μl, accord-
ing to the manufacturer's recommendations. Identical
reactions devoid of reverse transcriptase (-RT) were carried
out in parallel and did not lead to any DNA amplification
of predicted molecular weight in contrast to reverse tran-
scriptase-containing reactions. Reactions containing H20
instead of cDNA were also used in negative controls (data
not shown).
A RT-PCR approach was used for the analysis of defensin
expression in A549 and 16HBE human respiratory cell
lines, as well as in primary culture of human respiratory
cells exposed to RC, SC, or HF. Gene-specific primers for
hBD1 and hBD2 were designed according to the
sequences available at the National Center for Biotechnol-
ogy Information http://www.ncbi.nlm.nih.gov/ in order
to amplify specific cDNA sequences and avoid genomic
DNA amplification. In this respect, primer sequences were
designed to cover at least two subsequent exons, the
human beta-defensin (HBD) -1 and -2 (NCBI accession #
NM 005218.3 and NM 004942.2, respectively). It should
be observed that hBD2 is now referred to as hBD-4 in the
NCBI database. However, we decided to use the term,
hBD2, since it is widely used in scientific literature today
[53]. For the analysis of hBD8, hBD9 and hBD18, we
relied on previous studies; the primers and PCR condi-
tions were used as described in [10].
The PCR-amplified cDNA band of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH, NCBI accession # NM
2046.3) was used as an internal control with the predicted
size of 473 bp. In each reaction, the initial denaturing step
was 94°C for 8 min, followed by 32–38 cycles [denatura-
tion at 94°C for 40 seconds, annealing at 56–61°C
(according to primer melting temperature) for 40 s and
elongation at 72°C for 1 minute]. The final elongation
step was 72°C for 7 min. The primer annealing tempera-
tures, cycles and predicted PCR product sizes for the tran-
scripts investigated are summarised in Table 1. The PCR-
amplified cDNA products were separated by electrophore-
sis on a 2% agarose gel and visualised by ethidium bro-
mide after staining. The forward primers (f) and reverse
primers (r) used are presented in Table 1. Identification of
each defensin was confirmed by direct sequencing of
respective PCR products, using upstream PCR primers
(DNA Sequencing Facility, Qiagen, France).
Quantitative Real Time PCR
The level of mRNA for HBD2, HBD9 and GAPDH in
human cells was quantified using real time PCR analysis.
Three different experiments were performed. Isolation of
total RNA with TRIzol Reagent and synthesis of cDNA was
performed as described above. To perform real time PCR,
gene-specific primers were designed according to the
sequences available at the National Center for Biotechnol-
ogy Information http://www.ncbi.nlm.nih.gov/, using
Beacon Designer 2 software (Table 2).
In order to amplify specific cDNA sequences and to avoid
genomic DNA amplification, all primer sequences were
designed to cover at least two subsequent exons (Table 2).
Relative quantification relates the PCR signal of the target
transcript in a treatment group to that of an untreated con-
trol. For each primer-pair, the amplification efficiency was
determined by serial dilution experiments and the result-
ing efficiency coefficient was used for quantification of the
products [54]. Each 25 μl Quantitative PCR mixture
included 5 microl of DNA, 0.08 μl of primers (300 nM),
12.5 μl of CYBR green IQ supermix (2×) (ABgene) and
H2O. Quantitative PCR amplification was carried out on
an iCycler iQ system (Bio-Rad, Marne la Coquette,
France) with the following parameters: 15 min at 95°C
and 40 cycles of two steps consisting of 30s at 95°C, 30 s
at 55°C. The relative quantification of the mRNA levels of
the target genes was determined using the deltaCT –
method [55]. Briefly, the amount of target was normalised
to the endogenous reference gene GAPDH: deltaCT = CT
(target gene) – CT (GAPDH) where CT represents the cycle
number required to reach a defined threshold target abun-
dance. The relative mRNA level was calculated as × del-
Table 2: Primer sequences and annealing temperatures (Real 
Time PCR)
Primers Sequences Conditions
hBD2f
hBD2r
5'-tatctcctcttctcgttcctcttc-3'
5'-ccacaggtgccaatttgtttatac-3'
40 cycles, 55°C,
2.5% DMSO
hBD9f
hBD9r
5'-ggcctaaatccaggtgtgaa-3'
5'-tcaaatgttggcaagtggag-3'
40 cycles, 55°C
GAPDHf
GAPDHr
5'-acccactcctccacctttgac-3'
5'-tccaccaccctgttgctgtag-3'
40 cycles, 55°CBMC Microbiology 2009, 9:33 http://www.biomedcentral.com/1471-2180/9/33
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taCT (x = Primer efficiency) (Pfaffl, 2001). All reactions
were performed in triplicate and included a negative (-RT)
control without reverse transcriptase.
Neutralising anti-IL-1  antibody
Experiments designed to analyse the role of IL-1 β in A.
fumigatus-induced defensin expression were performed
using real time PCR. 5 × 106 of A549 or 16HBE cells were
placed in six well plates in 1.5 ml of the corresponding
medium and grown until confluence. The cells were
divided into three groups. The cells of the first group were
exposed to either A. fumigatus morphotypes or beads for
18 hours as described above. Neutralising anti-IL-1β anti-
body (10 μg/ml) was added to the cells of the second
group prior exposure to A. fumigatus organisms or beads
for the same period. The amount of neutralising antibody
was equal to that used in the experiments devoted to the
study of the role of Il-1β synthesized by the monocytes
infected with Streptococci [56]. Normal mouse immu-
noglobulin (10 μg/ml) was used instead of neutralising
antibody for the third group of cells. After collection of
cells, RNA were isolated using TRIzol reagent and real
time PCR was performed as described above.
Immunofluorescence
Either A549 or 16HBE cells were seeded at 5 × 105 cells per
well in 1 ml of DMEM/F12 on 18-mm-diameter cover
slips (Marienfeld, Germany) in 12 well plates (Nunc,
NuclonTM Surface) in triplicate and grown for 16 h at
37°C. After washing the cover slips with 5% BSA/PBS
(BSA, Fraction V, Sigma), the cells were exposed to either
106 fixed conidia or to 20 μl of the fixed HF solution (20
mg of dry weight/ml), or 5 × 106 latex beads for 24 hours.
The untreated cell culture was used as a negative control.
The treatment with 20 ng of Il-1β, a well-known inductor
of defensins [57], was used as a positive control. In some
experiments, the cells were treated with 10 ng/ml of TNF-
α. The cells were then fixed with freshly prepared 4% solu-
tion of paraformaldehyde for 30 min at 37°C, followed
by permeabilisation in 0.05% of Triton/PBS solution. The
slides were then incubated in 5% BSA/PBS, and then in a
solution of 10% normal goat serum (Sigma). After wash-
ing, rabbit anti-human hBD2 (Peptide Institute 234) at a
dilution of 1:250 was applied as a primary antibody over-
night at 4°C, followed by incubation with FITC-labelled
goat anti-rabbit secondary antibody (Sigma, Ac35-FITC)
at a dilution of 1:300 for 4 hours at room temperature
[58]. After washing, the cover slips were mounted on
slides with ProLong antifade Vectashield (Vectashield,
Biovalley). Samples were viewed with a Zeiss fluorescence
microscope using ×400 magnification. For each sample,
cells from five random fields were counted and the per-
centage of the cells stained with anti-defensin-2 antibody
was calculated as the number of stained cells divided by
the total number counted, multiplied by 100. The epithe-
lial cells incubated with normal rabbit serum at a dilution
of 1:250 (Sigma, 10 mg/ml) as a negative control showed
no reactivity.
Analysis of co-localisation of intracellular hBD-2 and A. 
fumigatus conidia or hyphal fragments
Co-localisation experiments were performed according to
the method described by Botterel at al. with modifications
[32]. After exposing the cells to 106  per millilitre of
medium of RC, SC or 20 μl of the standard HF solution
(35 mg of dry weight/ml) for 18 hours, the cells were fixed
and permeabilised as indicated above. The cells were then
labelled with primary rabbit anti-hBD2 antibody (Peptide
Institute 234) at a dilution of 1:250 overnight at 4°C, fol-
lowed by incubation with Tex Red-labelled goat anti-rab-
bit secondary antibody (Sigma) at a dilution of 1:300 for
1 hour at 37°C. After washing in PBS, the cover slips were
mounted on slides with ProLong antifade Vectashield
(Vectashield, Biovalley, USA). Samples were viewed with
a Zeiss fluorescence microscope using ×400 magnification
and the images were compared to the phase-contrast
images in order to identify stained internalised A. fumiga-
tus organisms.
Detection of hBD2 in cell supernatants
Analysis of the hBD2 in cell supernatants was performed
by sandwich-ELISA. Either A549 or 16HBE cells were
seeded at 106 cells per well in 1 ml of DMEM/F12 in 12
well plates in triplicate and grown for 24 h at 37°C. Pri-
mary culture HNT cells were grown for 48 hours in BEGM
medium as described above. The cells were then exposed
to 106 per millilitre of medium of RC, SC or 20 μl of the
standard HF solution (35 mg of dry weight/ml) for 18
hours. Cell supernatants were then centrifuged at 9000 g
for 10 min at 4°C and analysed for the presence of hBD2
with a commercial ELISA kit (Antigenix America, Inc., NY,
USA) according to the manufacturer's instructions.
Briefly, a 96-well ELISA plate (Nunc, NY, USA) was coated
with 100 μl of 0.5 μg/ml of capture anti-hBD2 antibody.
The plate was sealed and incubated overnight at room
temperature. After washing with phosphate buffer solu-
tion (PBS) containing 0.05% Tween 20, non-specific
binding sites of the wells were blocked with 200 μl of
0.1% Bovine Serum Albumin (BSA)/PBS solution for 1
hour at room temperature. The wells were then washed
again and 100 μl of cell supernatants or standard recom-
binant hBD2 in duplicate were added to the wells for 2
hours at room temperature. Serial dilutions of standard
hBD2 from 10 ng/ml to 0.01 ng/ml were performed in
diluent containing 0.1 BSA in 0.05% Tween 20/PBS. After
washing, 100 μl of tracer biotinilated antibody was added
to the wells at a concentration of 0.25 μg/ml for 2 hours
at room temperature. The wells were then washed again
and streptavidin-horse radish peroxidise solution at a con-
centration of 1 μg/ml was added for 30 minutes at roomBMC Microbiology 2009, 9:33 http://www.biomedcentral.com/1471-2180/9/33
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temperature, followed by intensive washing. Liquid chro-
mogenic substrate (3, 3', 5, 5'-Tetramethyl-Benzidine)
solution was used for colour development. The ELISA
plate was read using a 96-well plate reader IEMS,
THERMO LABSYSTEMS (Thermo Fisher Scientific, Cergy-
Pontoise, France) at 450 nm (correction set at 650 nm)
with 5 min intervals for 20 minutes. The sensitivity of
ELISA for hBD2 was 10 pg/ml.
Analysis of defensin expression by cells treated with 
inhibitors of protein synthesis and gene transcription
To examine the mechanism(s) for inducible defensin
expression in response to A. fumigatus, human airway epi-
thelial cells A549 or 16HBE were pre-treated with either
2.5 μg of cycloheximide (an inhibitor of protein synthe-
sis) per ml, 0.5 μg of actinomycin D (an inhibitor of RNA
transcription) per ml, or DMSO (vehicle control), 1 h
before exposure to A. fumigatus for an additional 6 or 18
hours. In this study, we used lower doses of actinomycin
D and cycloheximide than were previously described [33],
in order to avoid their toxic effect during incubation of the
cells for 18 hours. The viability of human cells as assessed
by trypan blue and total RNA yield were checked after
each treatment, and no differences were found between
experimental and untreated control cells.
Statistical analysis
The differences in the percentage of the cells positively
stained with anti-defensin antibody in the cell cultures
exposed or not to A. fumigatus were assessed by analysis of
variance. P-values <0.05 were considered to be significant.
Tukey's honestly significant difference test was applied for
comparison of means between groups. The values are
expressed as mean ± SEM. At least three different assays
were performed per experiment
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